ARCH DEVELOPMENT CORPORATION
Patent Owner
Stats
- 153 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jul 08, 2014 most recent publication
Details
- 153 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 14,145 Total Citation Count
- Nov 12, 1981 Earliest Filing
- 250 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8772261 Treatment of tumors with genetically engineered herpes virusOct 19, 12Jul 08, 14[A61K, C12N]
7838512 DNA damaging agents in combination with tyrosine kinase inhibitorsMay 02, 06Nov 23, 10[A61K]
7799535 Methods for identifying factors that control the folding of amyloid proteins of diverse originDec 08, 98Sep 21, 10[C12Q, G01N]
7592317 Constitutive gene expression in conjuction with ionizing radiationAug 11, 94Sep 22, 09[A61K, C12N]
7235366 Methods of identifying agonists and antagonists of opioid receptorsMay 31, 95Jun 26, 07[G01N]
7192711 Compositions and methods involving methyladenosine phosphorylase in the diagnosis and treatment of proliferative disordersMar 22, 05Mar 20, 07[C12Q]
7184582 Method, system and computer readable medium for an intelligent search workstation for computer assisted interpretation of medical imagesMar 08, 04Feb 27, 07[G06K]
7078396 Method of treating disorder related to high cholesterol concentrationNov 08, 02Jul 18, 06[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0164,811 DNA DAMAGING AGENTS IN COMBINATION WITH TYROSINE KINASE INHIBITORSAbandonedJun 26, 12Jun 27, 13[A61N]
8318691 Treatment of tumors with genetically engineered herpes virusExpiredJun 07, 10Nov 27, 12[A61K]
2012/0135,435 Methods for Identifying Factors That Control the Folding of Amyloid Proteins of Diverse OriginAbandonedAug 11, 10May 31, 12[C12Q, G01N]
2011/0053,240 DNA DAMAGING AGENTS IN COMBINATION WITH TYROSINE KINASE INHIBITORSAbandonedOct 13, 10Mar 03, 11[C12N]
7306801 Methods of therapy for cancers characterized by overexpression of the HER2 receptor proteinExpiredMay 14, 01Dec 11, 07[A61K]
2006/0251,626 Efficient and stable in vivo gene transfer to cardiomyocytes using recombinant adeno-associated virus vectorsAbandonedJun 09, 06Nov 09, 06[A61K, C12N]
7115258 Vesicular monoamine transporter gene therapy in parkinson's diseaseExpiredOct 31, 02Oct 03, 06[A01N]
7078387 Efficient and stable in vivo gene transfer to cardiomyocytes using recombinant adeno-associated virus vectorsExpiredDec 28, 99Jul 18, 06[A01N]
2006/0147,907 Methods for detection of promoter polymorphism in a UGT gene promoterAbandonedOct 21, 02Jul 06, 06[C12Q, C12P]
7070968 DNA damaging agents in combination with tyrosine kinase inhibitorsExpiredFeb 24, 03Jul 04, 06[C12N]
6984619 Method for protection against tumor metastasis formationExpiredMar 13, 00Jan 10, 06[A01N, C12Q]
6972196 Making surfaces inert by modifying with alkanethiolatesExpiredOct 11, 00Dec 06, 05[C12Q, C12N]
6916610 Method for generation of longer cDNA fragments from sage tags for gene identificationExpiredDec 22, 00Jul 12, 05[C07H, C12Q, C12P]
6898303 Method, system and computer readable medium for the two-dimensional and three-dimensional detection of lesions in computed tomography scansExpiredJan 16, 01May 24, 05[G06K]
6870037 Methylthioadenosine phosphorylase compositions and methods of use in the diagnosis and treatment of proliferative disordersExpiredJul 01, 96Mar 22, 05[C07H, C12Q]
6836558 Method, system and computer readable medium for identifying chest radiographs using image mapping and template matching techniquesExpiredMar 26, 01Dec 28, 04[G06K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
